Company / Shareholders' Equity
Orthofix Medical Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$503.1M
FY2025
5-year range
$327.6M / $503.1M
FY2021-FY2025
Trend
+49.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity returned to growth in FY2025 after 2 years of decline, reaching $503M.
Based on SEC 10-K filings.
$503M in FY2025 with a 5-year CAGR of +8.4%.
Improved from $337M to $503M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +12.1%
- 5-Year CAGR
- +8.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +8.4%, indicating consistent growth.
- In FY2025, shareholders' equity increased 49.4% year-over-year.
- Lowest shareholders' equity in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $503.1M | +49.4% |
| FY2024 | $336.9M | -0.0% |
| FY2023 | $336.9M | -5.6% |
| FY2022 | $356.9M | +8.9% |
| FY2021 | $327.6M | -2.3% |
| FY2020 | $335.4M | +13.1% |
| FY2019 | $296.6M | +12.6% |
| FY2018 | $263.5M | -9.2% |
| FY2017 | $290.3M | -3.1% |
| FY2016 | $299.6M | +1.3% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 28, 2026